Sartorius Stedim Biotech S.A.
SRTOY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $825 | $745 | $745 | $751 |
| % Growth | 10.7% | 0.1% | -0.9% | – |
| Cost of Goods Sold | $442 | $400 | $388 | $435 |
| Gross Profit | $383 | $345 | $356 | $316 |
| % Margin | 46.4% | 46.3% | 47.9% | 42.1% |
| R&D Expenses | $35 | $32 | $39 | $37 |
| G&A Expenses | $0 | $52 | $40 | $52 |
| SG&A Expenses | $184 | $167 | $167 | $174 |
| Sales & Mktg Exp. | $0 | $116 | $127 | $122 |
| Other Operating Expenses | $0 | $17 | $9 | -$4 |
| Operating Expenses | $219 | $216 | $215 | $207 |
| Operating Income | $163 | $129 | $141 | $110 |
| % Margin | 19.8% | 17.3% | 19% | 14.6% |
| Other Income/Exp. Net | -$61 | -$36 | -$26 | -$69 |
| Pre-Tax Income | $102 | $93 | $115 | $41 |
| Tax Expense | $27 | $24 | $30 | -$5 |
| Net Income | $75 | $69 | $86 | $46 |
| % Margin | 9.1% | 9.2% | 11.5% | 6.1% |
| EPS | 0.008 | 0.069 | 0.088 | 0.047 |
| % Growth | -88.8% | -21.6% | 87.2% | – |
| EPS Diluted | 0.008 | 0.069 | 0.088 | 0.047 |
| Weighted Avg Shares Out | 9,730 | 993 | 973 | 968 |
| Weighted Avg Shares Out Dil | 9,730 | 993 | 973 | 968 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5 | $0 | $38 | -$21 |
| Interest Expense | $60 | $31 | $63 | $11 |
| Depreciation & Amortization | $92 | $78 | $77 | $81 |
| EBITDA | $254 | $201 | $256 | $133 |
| % Margin | 30.8% | 27% | 34.4% | 17.7% |